Search results
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 7 hours agoNovavax , Inc. (NASDAQ: NASDAQ:NVAX) has announced its submission for an amended Emergency Use...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 1 day agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
COVID shots should target JN.1 variant in fall 2024 campaign, US FDA says
Stars and Stripes· 7 days agoThe Food and Drug Administration’s advisory is in line with European and World Health Organization...
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 14 hours agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Zacks via Yahoo Finance· 5 days agoModerna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19...
There's another COVID variant you should know about: KP.3 now makes up 25% of COVID cases
USA Today· 6 days agoThe Centers for Disease Control and Prevention data shows that a new COVID variant, the KP.3...
Healthy Returns: What we know about the next round of Covid vaccines
CNBC· 2 days agoA new round of Covid shots will likely reach Americans in the coming months. Here's what we know...
Moderna Falls, Though Says Covid/Flu Shot Topped Rivals
Investor's Business Daily· 4 days agoIn a study of about 8,000 people, Moderna's combination vaccine proved it's not inferior to the...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 2 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
Zacks via Yahoo Finance· 3 days agoData from a late-stage study shows that Moderna's (MRNA) experimental COVID-19-influenza combination...